About David Kuter, MD, DPhil

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass General Cancer Center: Hematology Oncology
55 Fruit St.
Boston, MA 02114
Phone: 617-724-4000
Phone: 617-726-8033
Fax: 617-724-6801

Mass General Cancer Center in Danvers
102 Endicott St.
Danvers, MA 01923
Phone: 978-882-6060

Medical Education

  • MD, Harvard Medical School
  • D.Phil., Oxford University Medical School
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Hematology, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine
  • Medical Oncology, American Board of Internal Medicine

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Current areas of ongoing research:

  • Hereditary hemorrhagic telangiectasis (HHT): NIH sponsored grant to assess effect of pomalidomide to reduce bleeding in patients with HHT.
  • Immune thrombocytopenia (ITP): NIH sponsored grant to assess effect of addition of mycophenolate to standard of care for patients with ITP.
  • Heparin-induced thrombocytopenia (HIT): lead in 17 center NIH-sponsored study of the natural history and treatment of HIT
  • Polycythemia vera (P.vera): Incyte Corp study (Reveal Study) to assess the natural history, treatment and quality of life of patients with P. vera.
  • ITP: Ph 1 study using anti-CD40 ligand antibody (BMS sponsor) to reduce the rate of thrombocytopenia in patients with ITP
  • ITP: Ph 1 study assessing the use of Staph protein A (Protalix, Inc) in the treatment of ITP
  • ITP: assessment of patients with ITP treated with TPO receptor agonists--effect on longterm remission
  • ITP: assessment of TPO receptor agonists in raising the platelet count of thrombocytopenic patients about to have surgery
  • ITP: study of platelet function in patients with ITP after treatment with romiplostim
  • Autoimmune hemolytic anemia (AIHA): creator and major site for international registry for patients with this disorder.

Publications

  • Selected peer-reviewed publications (of over 300)

    • Kuter DJ, Beeler D, Rosenberg RD. The purification and characterization of megapoietin: a megakaryocyte growth promoting protein. Proc Natl Acad Sci 1994;91:11104-11108.
    • Kuter DJ, et al. Thrombopoiesis and Thrombopoietins: Molecular, Cellular, Preclinical, and Clinical Biology. Humana Press, New York, 1997.
    • Murphy MJ, Kuter DJ, Eds. Thrombopoietin: From Molecule to Medicine. AlphaMed Press, Miamisburg, OH, 1998.
    • Bussel J, Kuter DJ, George J, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J,Wasser J, Wiznitzer I, Kelly R, Chen CF, Nichol J. AMG 531, a thrombopoiesis-stimulating protein, for ITP. New Engl J Med 2006;355:1672-1681.
    • Kuter DJ, et al. Randomized, controlled, 6-month evaluation of AMG531 in patients with chronic immune thrombocytopenic purpura. Lancet 2008;371:395-403.
    • Kuter DJ et al. Romiplostim or standard of care in patients with immune thrombocytopenia. NEJM 2010;363:1889-1899.

Reviews: Comments and Ratings

5.0out of 5(238 Ratings, 117 Comments)

March 2025

Dr. Kuter continues to provide excellent care. He obviously care about my health and well being and for my understanding all the relevant information.


February 2025

A delight of a professional doctor who cares and is concern about my health.


February 2025

Dr. Kuter was wonderful. He reassured me that my leukemia is progressing very slowly. He was very positive about the outcome, listened carefully, remembered details from a year ago. He was absolutely great. I love him.


February 2025

Everything is good


February 2025

Great


February 2025

Many thanks to Dr. Kuter. I really appreciate the time he spent with me, and he was very prompt in his follow up after my initial visit.


February 2025

everything was good


February 2025

He was very thorough and explained everything.


February 2025

Dr. Kuter is an excellent physician. He spends the time talking to us and explaining the results of the blood test and how I'm progressing with my condition. He's excellent. I would recommend him to my friends and family. He's the best.


February 2025

Dr. Kuter's explanations were very clear. I am pleased he is my ITP doctor.

View More
Ratings and Comments Powered by NRC Health